Literature DB >> 8744584

HTLV infection in ELISA-negative blood donors.

G Zehender1, M Girotto, C De Maddalena, G Francisco, M Moroni, M Galli.   

Abstract

Human T lymphotropic viruses (HTLVs) have a limited spread in the general populations of Western countries. Consequently, the transfusional risk for HTLV is consider to be low in Italy and the screening for anti-HTLV-I/II antibodies has not yet been introduced. In 1992, 1087 blood donors attending a transfusional center in northern Italy underwent anti-HTLV-I/II screening carried out by means of two different ELISA tests. Eleven individuals who were negative at the first test were borderline at the second, eight of them showing reactivity to Western blot (WB). Polymerase chain reaction (PCR) for the detection of HTLV DNA, subsequently performed on the peripheral blood mononuclear cells of these 11 subjects, was positive in the same 8 WB-reactive donors. Five of them were infected by HTLV-II, and three by HTLV-1. Our results confirm that the sensitivity of the ELISA tests actually used for the detection of HTLV-I/II antibodies is low, and that HTLV-infected blood donors may be frequently undetected. Moreover, in our study population, the prevalence of HTLV infection (0.73%) was greater than that which might be expected from the existing seroepidemiological data in Italy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8744584     DOI: 10.1089/aid.1996.12.737

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  2 in total

1.  Evaluation of the INNO-LIA HTLV I/II assay for confirmation of human T-cell leukemia virus-reactive sera in blood bank donations.

Authors:  E C Sabino; M Zrein; C P Taborda; M M Otani; G Ribeiro-Dos-Santos; A Sáez-Alquézar
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

Review 2.  Specific pathogen free macaque colonies: a review of principles and recent advances for viral testing and colony management.

Authors:  JoAnn L Yee; Thomas H Vanderford; Elizabeth S Didier; Stanton Gray; Anne Lewis; Jeffrey Roberts; Kerry Taylor; Rudolf P Bohm
Journal:  J Med Primatol       Date:  2016-03-01       Impact factor: 0.667

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.